Tag: Zilver PTX

Data show Zilver PTX leads to fewer complications and shorter hospital...

At this year’s VEITHsymposium (19–23 November, New York, USA), Marc Bosiers presented data that show that patient treatment with the Zilver PTX stent has...

VIVA 2019: Zilver PTX shows benefits across different patient groups

At this year’s Vascular Interventional Advances (VIVA) conference (4–7 November, Las Vegas, USA), Michael D Dake presented data on Zilver PTX that supports the...

CIRSE 2019: New Cook Medical paclitaxel data confirm safety of Zilver...

New data on the use of Zilver PTX, Cook Medical’s paclitaxel-coated stent for peripheral arterial disease (PAD), confirm the safety of the device. These...

CX 2019: Cook leads the way to data transparency with release...

 There were calls for greater transparency and sharing of the available randomised controlled trial data of paclitaxel-coated devices at the CX 2019 Highlight Session, Paclitaxel:...
stellarex

Latest data from Philips reinforces the safety profile of Stellarex low-dose...

A new pooled analysis of patient-level data from Philips demonstrates the “strong safety profile” of the company's Stellarex drug-coated balloon (DCB) in above-the-knee studies,...

Data presented at LINC confirm the safety and effectiveness of Zilver...

Findings presented at the Leipzig Interventional Course (LINC; 22–25 January 2019, Leipzig, Germany) contradict the results of a meta-analysis published in the Journal of...

New Zilver PTX global data finds 76% freedom from TLR at...

Results from an aggregated data analysis of the use of the Zilver PTX drug-eluting peripheral stent (DES; Cook Medical) in challenging patient populations concluded...

Five-year evaluation of Zilver PTX stent in a real-world population continues...

Five-year results from a Japanese post-market surveillance study aimed at evaluating the Zilver PTX drug-eluting stent (DES) in a real-world population show consistently positive...

Cook Medical receives FDA approval for first 5mm diameter SFA drug-eluting...

Cook Medical have announced that a new 5mm diameter version of Zilver PTX was approved by the US Food and Drug Administration (FDA). It...

Eluvia outperforms Zilver PTX in IMPERIAL 12-month results

The Eluvia drug-eluting vascular stent system (Boston Scientific) shows superior primary patency compared to the Zilver PTX drug-eluting stent (Cook Medical), concludes the 12-month...

Cook Medical introduces a new length of Zilver PTX

Cook Medical has introduced the 140mm-length Zilver PTX drug-eluting peripheral stent in both 6 and 7mm diameters in the USA. The longer length comes...

Eluvia paclitaxel-eluting vascular stent system demonstrates promising three-year freedom from revascularisation

The three-year results from the MAJESTIC trial for Boston Scientific’s Eluvia paclitaxel-eluting vascular stent system at the Cardiovascular and Interventional Radiological Society of Europe...

Cook launches 140mm Zilver PTX drug-eluting stent

Cook has extended its Zilver PTX product portfolio with a 140mm drug-eluting stent. Physicians will now be able to treat longer lesions with just...

Zilver PTX with thumbwheel delivery system launched in France

Cook Medical has launched the Zilver PTX drug-eluting peripheral stent thumbwheel delivery system in France, with the French Health Ministry now having approved reimbursement...

Promising findings for novel drug-eluting peripheral stent

A new animal study, presented at EuroPCR (17–20 May, Paris), indicates that a novel, fluoropolymer-coated, self-expanding, paclitaxel-eluting peripheral stent (Eluvia, Boston Scientific) is associated...